James A. Mcnulty - Mar 16, 2024 Form 4 Insider Report for Inhibitor Therapeutics, Inc. (INTI)

Role
CHIEF FINANCIAL OFFICER, 10%+ Owner
Signature
/s/ James A. McNulty
Stock symbol
INTI
Transactions as of
Mar 16, 2024
Transactions value $
$0
Form type
4
Date filed
5/16/2024, 01:34 PM
Previous filing
May 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INTI Stock Option Award $0 +100K $0.00 100K Mar 16, 2024 Common Stock 100K $0.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock options were issued to the Reporting Person on March 16, 2024 pursuant to the Issuer's 2014 Equity Incentive Plan. The common stock options vested immediately.